Constant Therapy has raised between $3 million and $5 million from undisclosed investors for further product development and marketing push of its digital health exercises that support personalized stroke therapy.

The company — which technology is based on research that came out of Boston University — offers 15,000 exercises for speech, language and cognitive rehabilitation like picture matching and identifying the most suitable word in different situations. The service costs $20 per month or roughly $200 per year; and each of the parties involved (patients and care givers) get their own mobile app and, in the case of providers – a web-based dashboard. While patients can access the mentioned exercises, providers get to follow the patient’s progress or their lack off.

While patients can access exercises, providers get to follow the patient’s progress (or their lack off).Constant Therapy currently doesn’t charge clinicians and it’s looking to use the fresh capital to add more of them to its network. What’s more, the company is still testing few business models.

When it comes to product development, Constant Therapy is looking to expand its NeuroPerformance Engine to other neurological conditions such as epilepsy, dementia and also sees relevance for people with learning disabilities. Already, they’ve tested the technology at Northwestern Medical School on epilepsy patients, while researchers at Boston University are evaluating its use with dementia patients.

“We’re at a point when we’re seeing significant expansion with our product,” said Constant Therapy co-founder Veera Arantha.

In March of this year, the company hired Keith Cooper as CEO, who has served as president of Carbonite, and also served as RatePoint CEO.

[Via: MedCityNews]